Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-07-29
2008-07-29
Seaman, D. Margaret (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S304000, C546S091000, C546S126000
Reexamination Certificate
active
10342080
ABSTRACT:
Xanthenecarboxylates of formula 1wherein:A is a group selected fromX−is an anion with a single negative charge;R is hydroxy, methyl, hydroxymethyl, ethyl, —CF3, —CHF2, or fluorine;R1and R2, which are identical or different, are each C1-C5-alkyl which is optionally substituted by C3-C6-cycloalkyl, hydroxy, or halogen, orR1and R2together denote a —C3-C5-alkylene-bridge; andR3, R4, R3′, and R4′, which are identical or different, are each hydrogen, —C1-C4-alkyl, —C4-alkyloxy, hydroxy, —CF3, —CHF2, —CN, —NO2, or halogen,or a physiologically acceptable salt thereof, processes for preparing, them and their use in pharmaceutical compositions.
REFERENCES:
patent: 4042700 (1977-08-01), Banholzer et al.
patent: 4608377 (1986-08-01), Banholzer et al.
patent: 4783534 (1988-11-01), Banholzer et al.
patent: 5610163 (1997-03-01), Banholzer et al.
patent: 5654314 (1997-08-01), Banholzer et al.
patent: 5770738 (1998-06-01), Banholzer et al.
patent: 5952505 (1999-09-01), Banholzer et al.
patent: 6486321 (2002-11-01), Banholzer et al.
patent: 6506900 (2003-01-01), Banholzer et al.
patent: 2002/0115680 (2002-08-01), Meissner
patent: 2002/0119991 (2002-08-01), Meissner
patent: 2003/0199539 (2003-10-01), Germeyer et al.
patent: 2003/0207912 (2003-11-01), Eickmeier et al.
patent: WO 92/16528 (1992-10-01), None
patent: WO 01/04118 (2001-01-01), None
patent: WO 02/32899 (2002-04-01), None
van Zwieten et al. Cardiovascular drugs and therapy/sponsored by the International Society of Cardiovascular Pharmacotherapy, 1995, 9(1) : 159-67.
Xu et al. Chemical & Pharmaceutical Bulletin, 1998, 46(2): 231-41.
U.S. Appl. No. 10/345,911, Eickmeier, C. et al; Anticholinergics, Processes for the Preparation Thereof and Pharmaceutical Compositions filed Jan. 16, 2003.
U.S. Appl. No. 10/335,795, Germeyer, S. et al—Fluorenecarboxylic Acid Esters, Process for the Manufacture Thereof, and Use Thereof as Medicaments filed Jan. 2, 2003.
Bonner, T.I.: “New Subtypes of Muscarinic Acetylcholine Receptors,” Trends Pharmacol. Sci., 10, Suppl., 1989, pp. 11-15.
Scittkowski, K.: “Parameter Estimation in Systems of Nonlinear Equations,” Numer. Math. 68, 1994, pp. 129-142.
Germeyer Sabine
Meissner Helmut
Morschhaeuser Gerd
Pestel Sabine
Pieper Michael P.
Boehringer Ingelheim Pharma GmbH & Co. KG
Devlin Mary-Ellen M.
Morris Michael P.
Petka Wendy A.
Rahmani Niloofar
LandOfFree
Xanthenecarboxylates, processes for preparing them, and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Xanthenecarboxylates, processes for preparing them, and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Xanthenecarboxylates, processes for preparing them, and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3955723